Toremifene citrate tablets, also known as faltrate, are commonly used in clinical practice to treat post-menopausal women with breast cancer due to disruption of sex hormone levels in the body, with better therapeutic effects, fewer side effects and no dependence. Tamoxifen, on the other hand, is also used for the treatment of breast cancer and is often used after breast cancer surgery because of its anti-estrogenic effect, which can play an adjuvant role to prevent metastasis or recurrence. Therefore, there is no good or bad difference between the two drugs, but the most suitable drug is chosen according to the patient’s specific condition.